KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Non-cash Items (2019 - 2022)

Vir Biotechnology's Non-cash Items history spans 4 years, with the latest figure at $127.4 million for Q4 2022.

  • For Q4 2022, Non-cash Items fell 27.78% year-over-year to $127.4 million; the TTM value through Dec 2022 reached $127.4 million, down 27.78%, while the annual FY2022 figure was $127.4 million, 27.78% down from the prior year.
  • Non-cash Items for Q4 2022 was $127.4 million at Vir Biotechnology, up from $65.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $290.1 million in Q1 2021 and bottomed at $16.2 million in Q3 2019.
  • The 4-year median for Non-cash Items is $122.4 million (2020), against an average of $136.4 million.
  • The largest annual shift saw Non-cash Items surged 671.5% in 2021 before it tumbled 77.41% in 2022.
  • A 4-year view of Non-cash Items shows it stood at $55.1 million in 2019, then surged by 113.38% to $117.5 million in 2020, then skyrocketed by 50.13% to $176.4 million in 2021, then dropped by 27.78% to $127.4 million in 2022.
  • Per Business Quant, the three most recent readings for VIR's Non-cash Items are $127.4 million (Q4 2022), $65.5 million (Q1 2022), and $176.4 million (Q4 2021).